Literature DB >> 7522057

Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factor.

R Weide1, J Heymanns, H Köppler, M Tiemann, B Huss, K H Pflüger, K Havemann.   

Abstract

Severe neutropenia is a common feature in patients with T-large granular lymphocytic (LGL) leukemia. Neutropenia often causes severe infections and septicemia, thus representing a major cause of morbidity and mortality in this disease. We have treated two outpatients with T-LGL leukemia who had severe neutropenia (neutrophils < 0.2 x 10(9)/l) successfully with G-CSF (5 micrograms/kg daily, s.c.). After 10 days of treatment the neutrophil count was within the normal range and a severe oral infection healed rapidly. We conclude that G-CSF therapy is able to normalize the neutrophil count in T-LGL leukemia within a few days and that it can be used to treat severe infections in these patients even on an outpatient basis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522057     DOI: 10.1007/bf01695691

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  10 in total

1.  Successful treatment of T-gamma lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor.

Authors:  D F Lang; C S Rosenfeld; H S Diamond; R K Shadduck; Z R Zeigler
Journal:  Am J Hematol       Date:  1992-05       Impact factor: 10.047

Review 2.  Gene rearrangements and translocations in lymphoproliferative diseases.

Authors:  H Griesser; D Tkachuk; M D Reis; T W Mak
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

3.  Chronic T-cell lymphocytosis with neutropenia: report of a case studied with monoclonal antibody.

Authors:  A C Aisenberg; B M Wilkes; N L Harris; K A Ault; R W Carey
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

4.  Agranulocytosis associated with granular lymphocyte leukaemia: improvement of peripheral blood granulocyte count with human recombinant granulocyte colony-stimulating factor (G-CSF)

Authors:  T Kaneko; Y Ogawa; Y Hirata; S Hoshino; M Takahashi; K Oshimi; H Mizogichi
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

Review 5.  Clonal diseases of large granular lymphocytes.

Authors:  T P Loughran
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

6.  Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients.

Authors:  J C Brouet; M Sasportes; G Flandrin; J L Preud'Homme; M Seligmann
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

7.  Detection of T-cell receptor gamma chain V gene rearrangements using the polymerase chain reaction: application to the study of clonal disease cells in acute lymphoblastic leukemia.

Authors:  J J Taylor; D Rowe; I K Williamson; S E Christmas; S J Proctor; P G Middleton
Journal:  Blood       Date:  1991-05-01       Impact factor: 22.113

8.  Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.

Authors:  A A Bom-van Noorloos; H G Pegels; R H van Oers; J Silberbusch; T M Feltkamp-Vroom; R Goudsmit; W P Zeijlemaker; A E von dem Borne; C J Melief
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

9.  Chronic T cell lymphocytosis: a review of 21 cases.

Authors:  A C Newland; D Catovsky; D Linch; J C Cawley; P Beverley; J F San Miguel; E C Gordon-Smith; T E Blecher; S Shahriari; S Varadi
Journal:  Br J Haematol       Date:  1984-11       Impact factor: 6.998

10.  T lymphocytes involved in inhibition of granulopoiesis in two neutropenic patients are of the cytotoxic/suppressor (T3+T8+) subset.

Authors:  G C Bagby
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

  10 in total
  1 in total

Review 1.  The spectrum of large granular lymphocyte leukemia and Felty's syndrome.

Authors:  Xin Liu; Thomas P Loughran
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.